Synex Co., Ltd. (CEO Kim Young) participated in ‘BIO KOREA 5’ held at COEX, Seoul for three days from May 10 (Wed) to 12 (Fri).
Synex, a company specializing in healthcare consulting, was established in 1999 as its predecessor, ‘Synex Consulting’. At that time, the business was focused on medical device and drug import item approval and insurance listing consulting services. .
Currently, Synex is a healthcare integrated consultant company, providing market entry life cycle solutions in various fields of the medical field. In particular, it has recently established itself as a CRO with successful precedents for a number of high-level clinical trials, such as cutting-edge medical devices, biopharmaceuticals, and innovative medical products that require new market entry strategies.
Their CRO service is a service that provides consulting on advanced biopharmaceutical items such as cell therapy products, gene recombinant drugs, and gene therapy products that are attracting attention in the global pharmaceutical industry. As a so-called ‘Full-Service CRO’, the company explains that it is also effective in establishing a post safety management process for drug price listing, drug surveillance, and post-marketing surveillance, which are procedures after clinical trials.
In particular, Synex, which has participated in Bio Korea every year since 2012, set up its own booth at this year’s exhibition, and conducted on-site consultations for officials in the pharmaceutical bio industry based on its expertise in digital treatment consulting. As the regulatory barriers for strengthening safety management policies and biopharmaceuticals and convergence medical products are increasing day by day, the official emphasized that they want to help preemptively prepare regulatory measures.
Synex said, “Sinex is a CRO company with many successful precedents related to high-level clinical trials such as biopharmaceuticals, innovative medical products, and advanced medical devices, and has conducted customized consultations at the exhibition site every year.” I hope you get the necessary information and answers,” he said, explaining his reason for participating in this exhibition.
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th this year, was hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. Since 2006, BIO KOREA, which has been striving to promote the global status and continuous growth of the Korean health industry, has been strengthening its position as Korea’s representative bio-health international convention with world-renowned scholars and business experts participating every year. BIO KOREA 2023, together with domestic and foreign companies related to the health industry such as bio, pharmaceuticals, medical devices, cosmetics, and food, as well as companies and institutions of interest such as consulting, academia, and related organizations, offers various programs such as conferences, business partnering, exhibitions, and invest fairs. It goes on.